These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9547130)

  • 1. Response characteristics to antidepressants and placebo in post-traumatic stress disorder.
    Davidson JR; Malik ML; Sutherland SN
    Int Clin Psychopharmacol; 1997 Nov; 12(6):291-6. PubMed ID: 9547130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
    Sugarman MA; Kirsch I; Huppert JD
    J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of posttraumatic stress disorder with amitriptyline and placebo.
    Davidson J; Kudler H; Smith R; Mahorney SL; Lipper S; Hammett E; Saunders WB; Cavenar JO
    Arch Gen Psychiatry; 1990 Mar; 47(3):259-66. PubMed ID: 2407208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.
    Connor KM; Sutherland SM; Tupler LA; Malik ML; Davidson JR
    Br J Psychiatry; 1999 Jul; 175():17-22. PubMed ID: 10621763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder.
    Davidson JR; Colket JT
    Int Clin Psychopharmacol; 1997 Jan; 12(1):41-5. PubMed ID: 9179633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial.
    Martenyi F; Soldatenkova V
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):340-9. PubMed ID: 16356696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
    Zimmerman M; Holst CG; Clark HL; Multach M; Walsh E; Rosenstein LK; Gazarian D
    CNS Drugs; 2016 Dec; 30(12):1209-1218. PubMed ID: 27541608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
    Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing power of placebos in trials of antidepressants.
    Schneider LS; Small GW
    JAMA; 2002 Jul 24-31; 288(4):450. PubMed ID: 12132971
    [No Abstract]   [Full Text] [Related]  

  • 18. The increasing power of placebos in trials of antidepressants.
    Sapir M
    JAMA; 2002 Jul 24-31; 288(4):450. PubMed ID: 12132970
    [No Abstract]   [Full Text] [Related]  

  • 19. The increasing power of placebos in trials of antidepressants.
    Brandon TH; Irvin JE; Hendricks PS
    JAMA; 2002 Jul 24-31; 288(4):449-50. PubMed ID: 12132969
    [No Abstract]   [Full Text] [Related]  

  • 20. A typological model for estimation of drug and placebo effects in depression.
    Ross DC; Quitkin FM; Klein DF
    J Clin Psychopharmacol; 2002 Aug; 22(4):414-8. PubMed ID: 12172342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.